Otros idiomas Vivos Inc.

Acciones

RDGL

US92858K2042

Mercado cerrado - OTC Markets Otros sitios de cotización 21:58:48 20/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,17 ^USD	-4,76 %		-14,10 %	+135,13 %

09/05	Vivos Inc. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
18/03	Vivos Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Announces Radiogel(TM) Precision Radionuclide Therapy(TM) Receives FDA Breakthrough Device Designation	20/12
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
Vivos : Quarterly Progress Report - Form 8-K	11/10/23
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics	07/08/23
Vivos Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04/08/23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04/05/23
Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	04/05/23
VIVOS INC : Unregistered Sale of Equity Securities (form 8-K)	02/05/23
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	01/03/23
Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	01/03/23
Vivos Inc. Auditor Raises 'Going Concern' Doubt	01/03/23
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy	11/01/23
Vivos Inc Files A New Patent on Alternate Particles for Precision Radionuclide Therapy	11/01/23
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment	03/01/23
Vivos Inc. Files New Patent on Precision Radionuclide Therapy Support System Equipment	03/01/23
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	19/10/22
Vivos Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	19/10/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Vivos Inc.

Acciones

RDGL

US92858K2042

Otros idiomas

Filtros